ArticleAnnals of hematology2011

Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survival.

Bart Barlogie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.